we heart startups

+1 202 555 0180

Have a question, comment, or concern? Our dedicated team of experts is ready to hear and assist you. Reach us through our social media, phone, or live chat.

Japanese startup Craif secures $22M in Series C funding to advance AI-driven cancer detection, with plans to expand in the U.S. and enhance R&D; targets increasing its miSignal test from seven to ten cancers by year-end

Craif, a Japanese early cancer detection startup using AI and microRNA, secures $22M in Series C funding, raising its total to $57M. The funds will aid U.S. expansion and R&D. Craif’s urine-based miSignal test targets seven cancers, aims to cover ten by year-end.

Source: techcrunch.com

Prev Post

Meta’s celebrity-voiced chatbots engage in explicit chats with minors on Facebook and Instagram, WSJ reveals; instances represent 0.02% of interactions with under-18 users, with voices like John Cena’s used in inappropriate exchanges

Next Post

India struggles with shortage of AI experts, fulfilling only 40% of demand; salaries for these roles average Rs 25 lakh, with mid-senior positions reaching up to Rs 2 crore amid increasing need for agentic AI skills

Leave a Reply
Read next